Navigation Links
Letrozole Beats Tamoxifen in Breast Cancer Therapy

Novartis' Femara (letrozole), one of a new class of breast cancer drugs, worked better than standard therapy with tamoxifen in treating breast cancer in women// with advanced disease. Femara is a member of a new class of drugs called aromatase inhibitors, which work differently to prevent certain kinds of breast cancer than does tamoxifen.

This new drug, Letrozole shrank tumors better and helped more women survive. The US Food and Drug Administration (FDA) approved Femara as first-line hormonal treatment for advanced breast cancer in postmenopausal women. At that time, an FDA advisory panel enthusiastically backed Femara based on Novartis' research comparing the drug with a generic version of tamoxifen, the gold standard treatment for advanced breast cancer.

Femara was initially approved by the FDA in 1997 as treatment for advanced, hormonally sensitive breast cancer that had not responded to other treatments. Novartis believes Femara may also have potential early in the course of breast cancer and is studying the drug as a pre-surgical therapy.
'"/>




Page: 1

Related medicine news :

1. New Study Confers All Clear Status On Letrozole, Infertility Drug
2. Nasal Spray Beats Antihistamine
3. Identifying Irregular Heart Beats
4. Stomach Beats Can Tell the Truth About Lying
5. Radiation Overdose at the Beatson Oncology Centre
6. Radio Therapy To Cure Irregular Heart Beats
7. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
8. Dawn Machine Beats Wintertime Blues
9. Hypertension Treatment: US Beats Europe
10. Low-dose Aspirin Beats High-dose After Cardiac Surgery
11. Tamoxifen does not adversely affect the brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... March 30, 2017 , ... According to the American Society of ... putting it among the top 5 most popular minimally-invasive cosmetic procedures in the country. ... will be performed over the next 8-10 weeks. For anyone considering a hair removal ...
(Date:3/30/2017)... NC (PRWEB) , ... March 30, 2017 , ... ... will host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ... 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... women’s professional squash, announced it has enlisted New York City-based sports and entertainment ... will develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... Indianapolis, IN (PRWEB) , ... March 29, 2017 ... ... Benefits Study, this webinar provides insight into the challenges employers face in trying ... the complexity of managing employee benefits programs? Adding to the growing complexity, ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... YORK , March 30, 2017  Purcell Julie & ... shareholders nationwide, is investigating a potential breach of fiduciary duty ... (NASDAQ: SGYP ). If you ... obtaining additional information regarding this investigation, free of charge, please ... ...
(Date:3/29/2017)... Wound care devices and products are used ... The industry mainly consists of establishments engaged in manufacturing ... wounds caused by mechanical, chemical, thermal, and radiogenic trauma; ... diabetes, skin related diseases, immunological diseases, and other chronic ... the largest region in the wound care devices market ...
(Date:3/29/2017)... 2017 Global intravenous (IV) iron and oral iron ... growing at a CAGR of 5%. Iron ... to treat anemia or other iron deficiencies. Oral iron supplements ... However, in some cases, oral administrations are not capable of ... iron therapy comes into the picture. Global Intravenous ...
Breaking Medicine Technology: